Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3C0LO
|
|||
| Drug Name |
VAC20121
|
|||
| Synonyms |
ACI-35
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 1/2 | [1] | |
| Company |
JOHNSON & JOHNSON
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04445831) A Phase Ib/IIa Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Immunogenicity of Different Doses, Regimens and Combinations of Tau Targeted Vaccines in Subjects With Early Alzheimer's Disease. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.